MedTrace Logo

Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction

NCT02808767 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1226

Last updated 2017-08-11

No results posted yet for this study

Summary

This study evaluates the efficacy of Prasugrel and Ticagrelor in the treatment of acute myocardial infarction.

Conditions

Interventions

DRUG

Prasugrel

Prasugrel 60 mg loading dose and 10mg/5mg once daily maintenance dose

DRUG

Ticagrelor

Ticagrelor 180 mg loading dose and 90 mg twice daily maintenance dose

Sponsors & Collaborators

  • Faculty Hospital Kralovske Vinohrady

    lead OTHER_GOV

Principal Investigators

  • Zuzana Motovska, MD PhD · University Hospital Kralovske Vinohrady, Prague, Czech Republic

  • Petr Widimsky, Prof MD DrSc · University Hospital Kralovske Vinohrady, Prague, Czech Republic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-05-31
Completion
2017-05-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02808767 on ClinicalTrials.gov